lonoctocog alfa 1 UNT Injection [Afstyla]

RxCUI
1796384
RxNorm name
lonoctocog alfa 1 UNT Injection [Afstyla]
Display name
lonoctocog alfa 1 UNT Injection [Afstyla]
Full name
lonoctocog alfa 1 UNT Injection [Afstyla]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:58

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125591AfstylaAntihemophilic Factor (Recombinant), Single Chain351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AFSTYLA Antihemophilic Factor (Recombinant), Single ChainANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANTCSL Behring Lengnau AG51f19873-a63f-4229-9477-5da4ecf31cde2023-06-23Warnings, Adverse reactionsExact identifier
rxcui: 1796384

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
51f19873-a63f-4229-9477-5da4ecf31cdeAFSTYLA 1 UNT Injection [PSN] · lonoctocog alfa 1 UNT Injection [Afstyla] [SBD] · Afstyla 1 UNT Injection [SY]313These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. AFSTYLA ® [Antihemophilic Factor (Recombinant), Single Chain] Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 201620230623